Targeting type Iγ phosphatidylinositol phosphate kinase overcomes oxaliplatin resistance in colorectal cancer

Rationale: Oxaliplatin is a widely used chemotherapy drug for advanced colorectal cancer (CRC) and its resistance is a major challenge for disease treatment. However, the molecular mechanism underlying oxaliplatin resistance remains largely elusive. Methods: An integrative analysis was performed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Minhao, Wang, Hao, Zhao, Wei, Ge, Xiaoxiao, Huang, Wei, Lin, Fengjuan, Tang, Wenbo, Li, Ang, Liu, Sailiang, Li, Rong-Kun, Jiang, Shu-Heng, Xue, Junli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169372/
https://www.ncbi.nlm.nih.gov/pubmed/35673560
http://dx.doi.org/10.7150/thno.69863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169372/
https://www.ncbi.nlm.nih.gov/pubmed/35673560
http://dx.doi.org/10.7150/thno.69863

Ejemplares similares